OncoSec Medical Incorporated
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of OncoSec Medical Incorporated generated cash of -$32,138,339, which is more than the previous year. Cash used in financing activities reached the amount of -$1,161,623 last year. Net change in cash is therefore -$33,651,493.
Cash Flow
| 2013 | -5.53M | -114.55K | 5.47M |
|---|---|---|---|
| 2014 | -8.98M | -512.5K | 42.37M |
| 2015 | -17.65M | -1.43M | 13.26M |
| 2016 | -17.81M | -1.55M | 16.07M |
| 2017 | -17.34M | -21.56K | 64.00K |
| 2018 | -23.22M | -23.28M | 38.88M |
| 2019 | -29.00M | 23.20M | 27.19M |
| 2020 | -33.14M | 0 | 28.39M |
| 2021 | -41.79M | -799.60K | 68.20M |
| 2022 | -32.13M | -244.85K | -1.16M |
ONCS Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 45.95M | 20.35M | 25.14M | 3.80M | 11.44M | 28.74M | 32.03M | 37.85M | 4.97M | 5.14M |
Operating activities | ||||||||||
Net income | -34.17M | -45.16M | -42.25M | -30.27M | -39.13M | -21.44M | -26.88M | -21.24M | -12.01M | -7.15M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.06M | 1.07M | 990.28K | 243.71K | 334.49K | 379.98K | 355.58K | 664.59K | 780.11K | 736.87K |
Stock-based compensation expense | 1.64M | 5.13M | 3.51M | 3.49M | 0 | 0 | 0 | 0 | 0 | 452.12K |
| Deferred income tax benefit | 1.64M | 5.13M | 3.51M | 3.49M | 0 | 0 | 0 | 0 | 0 | 452.12K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -1.38M | -2.56M | 3.61M | -741.44K | 0 | -208.28K | 861.63K | 1.06M | 657.26K | 344.76K |
Cash generated by operating activities | -32.13M | -41.79M | -33.14M | -29.00M | -23.22M | -17.34M | -17.81M | -17.65M | -8.98M | -5.53M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -25.47M | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -244.85K | -799.60K | 0 | -9.88K | -65.15K | -21.56K | -1.55M | -1.43M | -512.5K | -114.55K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -244.85K | -799.60K | 0 | 23.20M | -23.28M | -21.56K | -1.55M | -1.43M | -512.5K | -114.55K |
Financing activities | ||||||||||
Common Stock Issued | 42.5K | 62.84M | 30M | 27.89M | 32.28M | 0 | 17.45M | 13.58M | 27.94M | 7.2M |
Payments for dividends | 0 | 0 | 0 | -567 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -567 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -619.10K | -138.24K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -1.16M | 68.20M | 28.39M | 27.19M | 38.88M | 64.00K | 16.07M | 13.26M | 42.37M | 5.47M |
Net Change In Cash | -33.65M | 25.59M | -4.79M | 21.34M | -7.64M | -17.30M | -3.28M | -5.81M | 32.88M | -171.33K |
Cash at end of period | 12.29M | 45.95M | 20.35M | 25.14M | 3.80M | 11.44M | 28.74M | 32.03M | 37.85M | 4.97M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |